Viatris logo

Viatris share price today

(VTRS)

Viatris share price is $12.52 & ₹1,063.90 as on 21 Dec 2024, 2.30 'hrs' IST

$12.52

0.39

(3.22%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Viatris share price in Dollar and Rupees. Guide to invest in Viatris from India. Also see the sentimental analysis on Indian investors investing in Viatris. Get details on the Indian mutual funds that are investing in Viatris. Get Analyst recommendations and forecasts along with all the Viatris's financials.

Viatris share price movements

  • Today's Low: $12.17
    Today's High: $12.56

    Day's Volatility :3.11%

  • 52 Weeks Low: $9.93
    52 Weeks High: $13.62

    52 Weeks Volatility :27.12%

Viatris Returns

PeriodViatris Inc.Sector (Health Care)Index (Russel 2000)
3 Months
9.15%
-11.1%
0.0%
6 Months
19.58%
-6.0%
0.0%
1 Year
16.9%
2.7%
0.0%
3 Years
-8.14%
0.6%
-19.7%

Viatris Key Statistics

in dollars & INR

Previous Close
$12.13
Open
$12.21
Today's High
$12.555
Today's Low
$12.165
Market Capitalization
$14.5B
Today's Volume
$53.0M
52 Week High
$13.6175
52 Week Low
$9.925
Revenue TTM
$15.0B
EBITDA
$4.6B
Earnings Per Share (EPS)
$-0.73
Dividend Yield
3.96%
Profit Margin
-5.87%
Quarterly Earnings Growth YOY
-0.71%
Return On Equity TTM
-4.34%

How to invest in Viatris from India?

It is very easy for Indian residents to invest directly in Viatris from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viatris stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viatris or VTRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viatris or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viatris shares which would translate to 0.068 fractional shares of Viatris as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Viatris, in just a few clicks!

Returns in Viatris for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viatris investment value today

Current value as on today

₹1,19,096

Returns

₹19,096

(+19.1%)

Returns from Viatris Stock

₹16,900 (+16.9%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Viatris

18%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Viatris on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 18% more investors are searching Viatris in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Viatris

NameShares HeldChange in Shares% of Assets
ICICI Prudential Value Discovery Fund Direct Plan Growth
5015365
682691.48
1.13%
Motilal Oswal S&P 500 Index Fund Direct Growth
10256
17.54
0.03%

Global Institutional Holdings in Viatris

  • Vanguard Group Inc

    11.82%

  • BlackRock Inc

    7.76%

  • State Street Corp

    5.29%

  • Davis Selected Advisers

    5.25%

  • T. Rowe Price Associates, Inc.

    4.09%

  • Amvescap Plc.

    2.56%

Analyst Recommendation on Viatris

Hold

    7%Buy

    57%Hold

    35%Sell

Based on 14 Wall street analysts offering stock ratings for Viatris(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
8
8
8
Sell
5
5
5

Analyst Forecast on Viatris

What analysts predicted

Upside of 7.43%

Current:

$12.52

Target:

$13.45

Insights on Viatris

  • Price Movement

    In the last 7 days, VTRS stock has moved down by -0.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 3.79B → 3.73B (in $), with an average decrease of 1.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -326.4M → 94.8M (in $), with an average increase of 444.3% per quarter
  • VTRS vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 18.3% return, outperforming this stock by 0.7%
  • Price to Sales

    ForVTRS every $1 of sales, investors are willing to pay $1.0, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Viatris Financials in INR & Dollars

FY18Y/Y Change
Revenue
$11.4B
↓ 3.98%
Net Income
$352.5M
↓ 49.35%
Net Profit Margin
3.08%
↓ 2.76%
FY19Y/Y Change
Revenue
$11.5B
↑ 0.58%
Net Income
$16.8M
↓ 95.23%
Net Profit Margin
0.15%
↓ 2.93%
FY20Y/Y Change
Revenue
$11.9B
↑ 3.87%
Net Income
$-669.9M
↓ 4087.5%
Net Profit Margin
-5.61%
↓ 5.76%
FY21Y/Y Change
Revenue
$17.9B
↑ 49.73%
Net Income
$-1.3B
↑ 89.45%
Net Profit Margin
-7.1%
↓ 1.49%
FY22Y/Y Change
Revenue
$16.3B
↓ 9.08%
Net Income
$2.1B
↓ 263.79%
Net Profit Margin
12.78%
↑ 19.88%
FY23Y/Y Change
Revenue
$15.4B
↓ 5.14%
Net Income
$54.7M
↓ 97.37%
Net Profit Margin
0.35%
↓ 12.43%
Q2 FY23Q/Q Change
Revenue
$3.9B
↑ 5.08%
Net Income
$264.0M
↑ 17.49%
Net Profit Margin
6.74%
↑ 0.71%
Q3 FY23Q/Q Change
Revenue
$3.9B
↑ 0.59%
Net Income
$331.6M
↑ 25.61%
Net Profit Margin
8.41%
↑ 1.67%
Q4 FY23Q/Q Change
Revenue
$3.8B
↓ 2.98%
Net Income
$-765.6M
↓ 330.88%
Net Profit Margin
-20.02%
↓ 28.43%
Q1 FY24Q/Q Change
Revenue
$3.7B
↓ 4.21%
Net Income
$113.9M
↓ 114.88%
Net Profit Margin
3.11%
↑ 23.13%
Q2 FY24Q/Q Change
Revenue
$3.8B
↑ 3.64%
Net Income
$-326.4M
↓ 386.57%
Net Profit Margin
-8.6%
↓ 11.71%
Q3 FY24Q/Q Change
Revenue
$3.7B
↓ 1.54%
Net Income
$94.8M
↓ 129.04%
Net Profit Margin
2.54%
↑ 11.14%
FY18Y/Y Change
Profit
$4.0B
↓ 16.34%
FY19Y/Y Change
Profit
$3.9B
↓ 2.6%
FY20Y/Y Change
Profit
$3.8B
↓ 2.59%
FY21Y/Y Change
Profit
$5.6B
↑ 46.85%
FY22Y/Y Change
Profit
$6.5B
↑ 16.53%
FY23Y/Y Change
Profit
$6.4B
↓ 0.9%
Q2 FY23Q/Q Change
Profit
$1.6B
↑ 4.31%
Q3 FY23Q/Q Change
Profit
$1.7B
↑ 5.14%
Q4 FY23Q/Q Change
Profit
$1.6B
↓ 4.77%
Q1 FY24Q/Q Change
Profit
$1.5B
↓ 6.62%
Q2 FY24Q/Q Change
Profit
$1.5B
↓ 0.72%
Q3 FY24Q/Q Change
Profit
$1.5B
↓ 2.27%
FY18Y/Y Change
Operating Cash Flow
$2.3B
↑ 13.41%
Investing Cash Flow
$-1.2B
↑ 23.97%
Financing Cash Flow
$-1.1B
↓ 42.37%
FY19Y/Y Change
Operating Cash Flow
$1.8B
↓ 22.97%
Investing Cash Flow
$-525.4M
↓ 56.59%
Financing Cash Flow
$-1.2B
↑ 7.16%
FY20Y/Y Change
Operating Cash Flow
$1.2B
↓ 31.71%
Investing Cash Flow
$-301.1M
↓ 42.69%
Financing Cash Flow
$-605.7M
↓ 48.19%
FY21Y/Y Change
Operating Cash Flow
$3.0B
↑ 144.92%
Investing Cash Flow
$-117.8M
↓ 60.88%
Financing Cash Flow
$-3.0B
↑ 397.28%
FY22Y/Y Change
Operating Cash Flow
$3.0B
↓ 2.13%
Investing Cash Flow
$1.5B
↓ 1390.75%
Financing Cash Flow
$-3.9B
↑ 28.75%
Q2 FY23Q/Q Change
Operating Cash Flow
$514.9M
↓ 46.98%
Investing Cash Flow
$-76.6M
↓ 89.78%
Financing Cash Flow
$-303.5M
↓ 68.86%
Q3 FY23Q/Q Change
Operating Cash Flow
$834.1M
↑ 61.99%
Investing Cash Flow
$-53.8M
↓ 29.77%
Financing Cash Flow
$-97.6M
↓ 67.84%

Viatris Technicals Summary

Sell

Neutral

Buy

Viatris is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Viatris Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Viatris Inc.
-6.36%
19.58%
16.9%
-8.14%
-23.38%
Neurocrine Biosciences Inc.
7.78%
1.35%
3.22%
59.15%
24.17%
Haleon Plc Spon Ads
0.41%
12.15%
18.17%
30.77%
30.77%
Zoetis Inc.
-6.85%
-4.07%
-15.68%
-32.03%
24.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Viatris Inc.
224.4
NA
0.07
2.69
-0.04
0.02
0.04
16.58
Neurocrine Biosciences Inc.
35.99
35.99
0.32
6.54
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
28.53
28.53
1.73
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
30.68
30.68
2.6
5.88
0.47
0.15
0.01
11.59
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Viatris Inc.
Hold
$14.5B
-23.38%
224.4
-5.87%
Neurocrine Biosciences Inc.
Buy
$13.7B
24.17%
35.99
17.21%
Haleon Plc Spon Ads
Buy
$44.1B
30.77%
28.53
10.75%
Zoetis Inc.
Buy
$73.8B
24.01%
30.68
26.55%

Viatris Dividend announcements

  • Viatris Dividends December, 2024

    In the quarter ending December,2024. Viatris has declared dividend of $0.12

    Read More

About Viatris

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.
Organization
Viatris
Employees
32000
CEO
Mr. Scott Andrew Smith Ph.D.
Industry
Health Technology

Management People of Viatris

NameTitle
Mr. Scott Andrew Smith Ph.D.
CEO & Director
Mr. Brian S. Roman
Chief Legal Officer
Ms. Theodora Mistras
Chief Financial Officer
Mr. Paul B. Campbell
Chief Accounting Officer, Senior VP & Corporate Controller
Mr. Ramkumar V. Rayapureddy
Chief Information Officer
Mr. Andrew Enrietti
Chief People Officer
Mr. Menassie Taddese M.B.A.
President of Emerging Markets
Mr. Derek Glover
Chief Quality Officer
Ms. Lara Ramsburg
Chief Corporate Affairs Officer
Dr. Jeffrey Nau MMS, Ph.D.
President of Viatris Eye Care Division

Important FAQs about investing in Viatris from India :

What is Viatris share price today?

Viatris share price today stands at $12.52, Open: $12.21 ; Previous Close: $12.13 ; High: $12.56 ; Low: $12.17 ; 52 Week High: $13.62 ; 52 Week Low: $9.93. The stock opens at $12.21, after a previous close of $12.13. The stock reached a daily high of $12.56 and a low of $12.17, with a 52-week high of $13.62 and a 52-week low of $9.93.

Can Indians buy Viatris shares?

Yes, Indians can invest in the Viatris (VTRS) from India.

With INDmoney, you can buy Viatris at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Viatris at zero transaction cost.

How can I buy Viatris shares from India?

It is very easy to buy Viatris from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viatris be purchased?

Yes, you can buy fractional shares of Viatris with INDmoney app.

What are the documents required to start investing in Viatris stocks?

To start investing in Viatris, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Viatris

Today’s highest price of Viatris (VTRS) is $12.56.

Today’s lowest price of Viatris (VTRS) is $12.17.

What is today's market capitalisation of Viatris

Today's market capitalisation of Viatris VTRS is 14.5B

What is the 52 Week High and Low Range of Viatris

  • 52 Week High

    $13.62

  • 52 Week Low

    $9.93

What are the historical returns of Viatris?

  • 1 Month Returns

    -6.36%

  • 3 Months Returns

    19.58%

  • 1 Year Returns

    16.9%

  • 5 Years Returns

    -23.38%

Who is the Chief Executive Officer (CEO) of Viatris

Mr. Scott Andrew Smith Ph.D. is the current Chief Executive Officer (CEO) of Viatris.